SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-081249
Filing Date
2023-07-14
Accepted
2023-07-14 16:31:28
Documents
12
Period of Report
2023-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2321234d1_8k.htm   iXBRL 8-K/A 27175
  Complete submission text file 0001104659-23-081249.txt   200253

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA uthr-20230626.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20230626_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20230626_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2321234d1_8k_htm.xml XML 3549
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26301 | Film No.: 231089461
SIC: 2834 Pharmaceutical Preparations